Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2200

Lilly’s oral lipid drug passes mid-stage test

$
0
0
Eli Lilly reported positive data for its drug candidate for elevated lipids, marking a key milestone for a potential oral option in a space dominated by injectable candidates. Lilly’s muvalaplin met the primary endpoint of ...

Viewing all articles
Browse latest Browse all 2200

Trending Articles